Abstract| Volume 13, ISSUE 3, e6-e7, May 2019

Evolocumab in Patients With Type 2 Diabetes and Dyslipidemia on Background Statin: Primary Results of the China Population from the BERSON Clinical Trial

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Clinical Lipidology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect